{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:48:52Z","timestamp":1772203732375,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,10]]},"DOI":"10.7759\/cureus.21077","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T14:34:17Z","timestamp":1641825257000},"source":"Crossref","is-referenced-by-count":9,"title":["The Progression of Chronic Myeloid Leukemia to Myeloid Sarcoma: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Hadia","family":"Arzoun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirra","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhosh Raja","family":"Thangaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siji  S","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubna","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.COT.0000554593.86214.e8","article-title":"A discussion about the field of hematology\/oncology","volume":"41","author":"Crilley P","year":"2019","unstructured":"Crilley P, Baratam P. A discussion about the field of hematology\/oncology. Oncol Times. 2019, 41:16. 10.1097\/01.COT.0000554593.86214.e8","journal-title":"Oncol Times"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky I","year":"2016","unstructured":"De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016, 6:441. 10.1038\/bcj.2016.50","journal-title":"Blood Cancer J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/2040620711410774","article-title":"Myeloid sarcoma: current approach and therapeutic options","volume":"2","author":"Avni B","year":"2011","unstructured":"Avni B, Koren-Michowitz M. Myeloid sarcoma: current approach and therapeutic options. Ther Adv Hematol. 2011, 2:309-16. 10.1177\/2040620711410774","journal-title":"Ther Adv Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v8.i3.321","article-title":"Myeloid sarcoma presenting as a colon polyp and harbinger of chronic myelogenous leukemia","volume":"8","author":"Rogers R","year":"2016","unstructured":"Rogers R, Ettel M, Cho M, Chan A, Wu XJ, Neto AG. Myeloid sarcoma presenting as a colon polyp and harbinger of chronic myelogenous leukemia. World J Gastrointest Oncol. 2016, 8:321-5. 10.4251\/wjgo.v8.i3.321","journal-title":"World J Gastrointest Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2011.23.S2.S214","article-title":"Primary granulocytic sarcoma of the face","volume":"23","author":"Hwang JI","year":"2011","unstructured":"Hwang JI, Kim TY. Primary granulocytic sarcoma of the face. Ann Dermatol. 2011, 23:214-7. 10.5021\/ad.2011.23.S2.S214","journal-title":"Ann Dermatol"},{"key":"ref6","article-title":"Case report: a large extramedullary granulocytic sarcoma as the initial presenting feature of chronic myeloid leukemia","volume":"7","author":"Jenkins CI","year":"2005","unstructured":"Jenkins CI, Sorour Y. Case report: a large extramedullary granulocytic sarcoma as the initial presenting feature of chronic myeloid leukemia. MedGenMed. 2005, 7:23.","journal-title":"MedGenMed"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid sarcoma: presentation, diagnosis, and treatment","volume":"17","author":"Almond LM","year":"2017","unstructured":"Almond LM, Charalampakis M, Ford SJ, Gourevitch D, Desai A. Myeloid sarcoma: presentation, diagnosis, and treatment. Clin Lymphoma Myeloma Leuk. 2017, 17:263-7. 10.1016\/j.clml.2017.02.027","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2014.11929127","article-title":"Myeloid sarcoma as the presenting symptom of chronic myelogenous leukemia blast crisis","volume":"27","author":"Levy RA","year":"2014","unstructured":"Levy RA, Mardones MA, Burch MM, Krause JR. Myeloid sarcoma as the presenting symptom of chronic myelogenous leukemia blast crisis. Baylor Univ Med Cent Proc. 2014, 27:246-9. 10.1080\/08998280.2014.11929127","journal-title":"Baylor Univ Med Cent Proc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2019.04.011","article-title":"Chronic myeloid leukemia manifested as myeloid sarcoma: review of literature and case report","volume":"64","author":"Palejwala AH","year":"2019","unstructured":"Palejwala AH, O'Connor KP, Shi H, Villeneuve L, Scordino T, Glenn CA. Chronic myeloid leukemia manifested as myeloid sarcoma: review of literature and case report. J Clin Neurosci. 2019, 64:269-76. 10.1016\/j.jocn.2019.04.011","journal-title":"J Clin Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.46658\/JBIMES-20-04","article-title":"Chapter 7: Systematic reviews of etiology and risk","author":"Tufanaru C","year":"2020","unstructured":"Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Chapter 7: Systematic reviews of etiology and risk. JBI Manual for Evidence Synthesis. Aromataris E, Munn Z (ed): The Joanna Briggs Institute, Adelaide; 2020. 04:221. 10.46658\/JBIMES-20-04"},{"key":"ref12","article-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses","author":"Wells GA","year":"2000","unstructured":"Wells GA, Shea B, O'Connell D, et al.. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Ottawa Hospital Research Institute, Ottawa; 2000."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.27","article-title":"Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy","volume":"6","author":"Chen Z","year":"2016","unstructured":"Chen Z, Wang W, Cortes JE, et al.. Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood Cancer J. 2016, 6:e418. 10.1038\/bcj.2016.27","journal-title":"Blood Cancer J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000727","article-title":"Clinicopathological, cytogenetic, and prognostic analysis of 131 myeloid sarcoma patients","volume":"40","author":"Kawamoto K","year":"2016","unstructured":"Kawamoto K, Miyoshi H, Yoshida N, Takizawa J, Sone H, Ohshima K. Clinicopathological, cytogenetic, and prognostic analysis of 131 myeloid sarcoma patients. Am J Surg Pathol. 2016, 40:1473-83. 10.1097\/PAS.0000000000000727","journal-title":"Am J Surg Pathol"},{"key":"ref15","article-title":"Myeloid sarcoma as the first sign of progression of chronic myeloid leukemia in medullary chronic phase: experience from a Tertiary Cancer Centre in Southern India","volume":"1","author":"Dasappa L","year":"2017","unstructured":"Dasappa L, Thanky AH, Kuntegowdanahalli L, et al.. Myeloid sarcoma as the first sign of progression of chronic myeloid leukemia in medullary chronic phase: experience from a Tertiary Cancer Centre in Southern India. Gulf J Oncol. 2017, 1:21-5.","journal-title":"Gulf J Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20176042","article-title":"Cutaneous myeloid sarcoma associated with chronic myeloid leukemia","volume":"92","author":"Vasconcelos ER","year":"2017","unstructured":"Vasconcelos ER, Bauk AR, Rochael MC. Cutaneous myeloid sarcoma associated with chronic myeloid leukemia. An Bras Dermatol. 2017, 92:50-2. 10.1590\/abd1806-4841.20176042","journal-title":"An Bras Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2019.1683107","article-title":"Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis","volume":"37","author":"Zhou T","year":"2020","unstructured":"Zhou T, Bloomquist MS, Ferguson LS, et al.. Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis. Pediatr Hematol Oncol. 2020, 37:76-89. 10.1080\/08880018.2019.1683107","journal-title":"Pediatr Hematol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5045\/br.2020.2019191","article-title":"Chronic phase of chronic myeloid leukemia presenting with myeloid sarcoma in an adolescent","volume":"55","author":"Lee HJ","year":"2020","unstructured":"Lee HJ, Gu MJ, Kong E, Lee JM. Chronic phase of chronic myeloid leukemia presenting with myeloid sarcoma in an adolescent. Blood Res. 2020, 55:112-5. 10.5045\/br.2020.2019191","journal-title":"Blood Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0984-4","article-title":"Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensity","volume":"56","author":"Frietsch JJ","year":"2021","unstructured":"Frietsch JJ, Hunstig F, Wittke C, et al.. Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensity. Bone Marrow Transplant. 2021, 56:101-9. 10.1038\/s41409-020-0984-4","journal-title":"Bone Marrow Transplant"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24275","article-title":"Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring","volume":"91","author":"Jabbour E","year":"2016","unstructured":"Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring. Am J Hematol. 2016, 91:252-65. 10.1002\/ajh.24275","journal-title":"Am J Hematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx219","article-title":"Chronic myeloid leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Hochhaus A","year":"2017","unstructured":"Hochhaus A, Saussele S, Rosti G, et al.. Chronic myeloid leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017, 28:41-51. 10.1093\/annonc\/mdx219","journal-title":"Ann Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/biology10020118","article-title":"Future approaches for treating chronic myeloid leukemia: CRISPR therapy","volume":"10","author":"Vuelta E","year":"2021","unstructured":"Vuelta E, Garc\u00eda-Tu\u00f1\u00f3n I, Hern\u00e1ndez-Carabias P, M\u00e9ndez L, S\u00e1nchez-Mart\u00edn M. Future approaches for treating chronic myeloid leukemia: CRISPR therapy. Biology (Basel). 2021, 10:118. 10.3390\/biology10020118","journal-title":"Biology (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.179937","article-title":"De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways","volume":"104","author":"Magistroni V","year":"2019","unstructured":"Magistroni V, Mauri M, D'Aliberti D, et al.. De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways. Haematologica. 2019, 104:1789-97. 10.3324\/haematol.2017.179937","journal-title":"Haematologica"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2016.11.005","article-title":"Preclinical approaches in chronic myeloid leukemia: from cells to systems","volume":"47","author":"Clarke CJ","year":"2017","unstructured":"Clarke CJ, Holyoake TL. Preclinical approaches in chronic myeloid leukemia: from cells to systems. Exp Hematol. 2017, 47:13-23. 10.1016\/j.exphem.2016.11.005","journal-title":"Exp Hematol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061709","article-title":"Chronic myeloid leukemia prognosis and therapy: criticisms and perspectives","volume":"9","author":"Russo D","year":"2020","unstructured":"Russo D, Garcia-Gutierrez JV, Soverini S, Baccarani M. Chronic myeloid leukemia prognosis and therapy: criticisms and perspectives. J Clin Med. 2020, 9:1709. 10.3390\/jcm9061709","journal-title":"J Clin Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00665","article-title":"New approaches and treatment combinations for the management of chronic myeloid leukemia","volume":"9","author":"Westerweel PE","year":"2019","unstructured":"Westerweel PE, Te Boekhorst PA, Levin MD, Cornelissen JJ. New approaches and treatment combinations for the management of chronic myeloid leukemia. Front Oncol. 2019, 9:665. 10.3389\/fonc.2019.00665","journal-title":"Front Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000497210","article-title":"Myeloid sarcoma","volume":"42","author":"Magdy M","year":"2019","unstructured":"Magdy M, Abdel Karim N, Eldessouki I, Gaber O, Rahouma M, Ghareeb M. Myeloid sarcoma. Oncol Res Treat. 2019, 42:224-9. 10.1159\/000497210","journal-title":"Oncol Res Treat"},{"key":"ref28","article-title":"Myeloid sarcoma as the presenting symptom of chronic myeloid leukemia chronic phase: a case report","volume":"6","author":"Mjali A","year":"2017","unstructured":"Mjali A, Hasan DM, Al-Anssari MJ, Muhsin RK, Hamandi A, Al-Shammari HHJ. Myeloid sarcoma as the presenting symptom of chronic myeloid leukemia chronic phase: a case report. World J Pharm Res. 2017, 6:10-5.","journal-title":"World J Pharm Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100773","article-title":"Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved","volume":"47","author":"Shallis RM","year":"2021","unstructured":"Shallis RM, Gale RP, Lazarus HM, et al.. Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved. Blood Rev. 2021, 47:100773. 10.1016\/j.blre.2020.100773","journal-title":"Blood Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s10006-019-00812-y","article-title":"A case of myeloid sarcoma of the mandibular gingiva as extramedullary relapse of acute myeloid leukemia","volume":"24","author":"Ishikawa S","year":"2020","unstructured":"Ishikawa S, Kato Y, Kabasawa T, et al.. A case of myeloid sarcoma of the mandibular gingiva as extramedullary relapse of acute myeloid leukemia. Oral Maxillofac Surg. 2020, 24:121-6. 10.1007\/s10006-019-00812-y","journal-title":"Oral Maxillofac Surg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2019.03.027","article-title":"Isolated myeloid sarcoma of the temporal bone: as the first clinical manifestation of acute myeloid leukemia in a patient of down's syndrome","volume":"58","author":"Marwah N","year":"2019","unstructured":"Marwah N, Bhutani N, Budhwar A, Sen R. Isolated myeloid sarcoma of the temporal bone: as the first clinical manifestation of acute myeloid leukemia in a patient of down's syndrome. Int J Surg Case Rep. 2019, 58:77-80. 10.1016\/j.ijscr.2019.03.027","journal-title":"Int J Surg Case Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05167-4","article-title":"Epidural myeloid sarcoma as the presenting symptom of chronic myeloid leukemia blast crisis","volume":"39","author":"Slouma M","year":"2020","unstructured":"Slouma M, Rahmouni S, Dhahri R, et al.. Epidural myeloid sarcoma as the presenting symptom of chronic myeloid leukemia blast crisis. Clin Rheumatol. 2020, 39:2453-9. 10.1007\/s10067-020-05167-4","journal-title":"Clin Rheumatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.79","article-title":"Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set","volume":"7","author":"Goyal G","year":"2017","unstructured":"Goyal G, Bartley AC, Patnaik MM, Litzow MR, Al-Kali A, Go RS. Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set. Blood Cancer J. 2017, 7:e592. 10.1038\/bcj.2017.79","journal-title":"Blood Cancer J"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-021-01328-y","article-title":"The myeloid sarcoma treated by Venetoclax with hypomethylating agent followed by stem cell transplantation: rare case report","volume":"21","author":"Shatilova A","year":"2021","unstructured":"Shatilova A, Girshova L, Zaytsev D, et al.. The myeloid sarcoma treated by Venetoclax with hypomethylating agent followed by stem cell transplantation: rare case report. BMC Women's Health. 2021, 21:184. 10.1186\/s12905-021-01328-y","journal-title":"BMC Women's Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/77985-the-progression-of-chronic-myeloid-leukemia-to-myeloid-sarcoma-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:25Z","timestamp":1707507685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/77985-the-progression-of-chronic-myeloid-leukemia-to-myeloid-sarcoma-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.21077","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,10]]}}}